Press release
Biosimulation Market Worth $2.88 Billion | Increase in R&D Investments in the Pharmaceutical and Biotechnology Industries
The growth of biosimulation market is majorly driven by factors such as the increase in R&D investments in the pharmaceutical and biotechnology industries, growing adoption of biosimulation software by regulatory bodies, technologically advanced QSP systems, need to curtail drug discovery and development costs, and growth in the biologics and biosimilars markets.According to a new market research report "Biosimulation Market by Product (Software, Molecular Simulation, In House, Contract Services), Application (Clinical Trials, PKPD, ADME), Delivery (Subscription, Ownership), End User (Biotech, Pharma Companies, CROs, Regulatory) - Global Forecast to 2022", published by MarketsandMarkets™, the market is expected to reach USD 2.88 Billion by 2022 from USD 1.38 Billion in 2017, at a CAGR of 15.9%.
Browse 187 market data Tables and 28 Figures spread through 180 Pages and in-depth TOC on "Biosimulation Market"
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=838&utm_source=Openpr-09-Dec-2019&utm_medium=PaidPR
The Biosimulation Market is highly competitive with the presence of several small and big players. Some of the players in the Biosimulation Market include Certara (US), Simulation Plus (US), Dassault Systèmes (France), Schrödinger (US), ACD/Labs (Canada), Chemical Computing Group (Canada), Physiomics (UK), Evidera (US), In silico biosciences (US), INOSIM Software (Germany), Insilico Biotechnology (Germany), LeadInvent Technologies (India), Rosa (US), Nuventra Pharma (US), and Genedata (Switzerland).
Biosimulation software expected to dominate the biosimulation market in 2017.
Based on product and service, the Biosimulation Market is segmented into software and services. In 2017, the biosimulation software segment is expected to account for the largest share of the biosimulation market. The high growth of this segment is attributed to the growing adoption of biosimulation software by pharmaceutical and research organizations and the increasing R&D investment for pharmaceutical research.
Based on end user, the pharmaceutical and biotechnology companies segment is projected to grow at the highest CAGR in Biosimulation Market.
Based on end user, the Biosimulation Market is segmented into research institutes, pharmaceutical and biotechnology companies, contract research organizations (CROs), regulatory authorities, and other end users (consulting firms, defense research and development organizations, nutraceutical companies, and food and agricultural companies).
The pharmaceutical and biotechnology companies segment is expected to register the highest CAGR during the forecast period. Increased R&D budgets of pharmaceutical and biotechnology companies and increasing adoption of inorganic growth strategies by different biosimulation service providers are likely to boost the adoption of biosimulation solutions in the pharmaceuticals and biotechnology industry.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=838&utm_source=Openpr-09-Dec-2019&utm_medium=PaidPR
North America to dominate the biosimulation market
In 2017, North America is expected to dominate the biosimulation market followed by Europe. The large share of this geographical segment is attributed to factors such as growth in the biotechnology and pharmaceutical industry, a large number of ongoing drug development processes, increased use of personalized medicine, and increasing R&D expenditure by pharmaceutical and biotechnology companies.
Request Bundle Reports:
https://www.marketsandmarkets.com/RequestBundleReport.asp?id=838&utm_source=Openpr-09-Dec-2019&utm_medium=PaidPR
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Biosimulation Market Worth $2.88 Billion | Increase in R&D Investments in the Pharmaceutical and Biotechnology Industries here
News-ID: 1877262 • Views: …
More Releases from MarketsandMarkets

Laser Interferometer Market Set to Grow at the Fastest Rate- Time to Grow your R …
The global laser interferometer market is expected to be valued at 315 million in 2024 and is projected to reach USD 447 million by 2029, at a CAGR of 7.2% from 2024 to 2029. Emerging applications in industries push the market's growth due to the growing demand for precision in the manufacturing sector. However, challenges such as higher initial investments and maintenance costs cause problems. Despite these, opportunities arise for…

With 19.6% CAGR, Battery Testing, Inspection, and Certification Market Growth to …
The battery testing, inspection, and certification market is projected to reach USD 36.7 billion by 2029 from USD 14.9 billion in 2024 at a CAGR of 19.6% during the forecast period. Increasing adoption of EVs and energy storage systems, rising enforcement of stringent standards to ensure battery safety, thriving portable electronics industry, and rapid advances in battery technology are the major factors contributing to the market growth.
Download PDF Brochure @…

Real-Time Location Systems Revolutionize Healthcare: Insights from MarketsandMar …
The global RTLS market for healthcare is projected to grow from USD 2.3 billion in 2024 to USD 5.7 billion by 2029, at a compound annual growth rate of 19.6% from 2024 to 2029. As it attracts more and more players who enter this market with innovative RTLS features for customers, the market for RTLS technology is rapidly increasing. Top companies in this market focus on healthcare, retail, and manufacturing…

Offsite Data Center Power Infrastructure Market Size to Reach $35.4 billion by 2 …
According to a research report "Offsite Data Center Power Infrastructure Market by Component (Solutions and Services), Vertical (BFSI, Media & Entertainment, Government & Defence, Healthcare, Manufacturing, IT & Telecom, Retail) and Region - Global Forecast to 2030" published by MarketsandMarkets, the market size for global offsite data center power infrastructure market is projected to reach approximately USD 35.4 billion by the year 2030, as compared to the estimated value of…
More Releases for Biosimulation
Key Trends Influencing the Growth of the Biosimulation Market in 2025: Innovatio …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
What Is the Expected CAGR for the Biosimulation Market Through 2025?
The size of the biosimulation market has seen a significant increase lately. This market is projected to expand from a total value of $4.47 billion in 2024 to $5.02 billion in 2025, indicating a compound annual growth rate (CAGR) of 12.2%. The historic…
Global Healthcare Expenditure Boosts Biosimulation Market Growth: A Significant …
The Biosimulation Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Biosimulation Market Size and Projected Growth Rate?
The size of the biosimulation market has expanded significantly in the past few years. Starting from a valuation of $4.47 billion in 2024, it's forecasted to…
Primary Catalyst Driving Biosimulation Market Evolution in 2025: Global Healthca …
What market dynamics are playing a key role in accelerating the growth of the biosimulation market?
The anticipated rise in global healthcare expenditure is predicted to bolster the biosimulation market throughout the forecast period. The uptick in healthcare expenses is expected to increase spending on drug development, consequently fueling revenue from biosimulation solutions. Currently, biosimulation software is utilized in drug development to imitate diseases. This software enables the conduct of virtual…
North America Biosimulation Market
The global biosimulation market is experiencing rapid expansion, driven by advancements in technology and the increasing demand for computational tools that can accelerate drug discovery, clinical trials, and regulatory processes. As of 2023, the market was valued at USD 3.5 billion and is projected to reach USD 14.1 billion by 2032, growing at a Compound Annual Growth Rate (CAGR) of 16.90% from 2024 to 2032.
Biosimulation, which involves the use of…
Global Biosimulation Market Research Report 2023-2029
Biosimulation report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Biosimulation market is projected to reach US$ 3686.5 million in 2029, increasing from US$ 1580.2 million in 2022, with the CAGR of 12.7% during the period of 2023 to 2029. Demand from Hospital and Scientific Research Institutions are the major drivers for the industry.
Global Biosimulation Market: Driven factors and Restrictions factors
The research…
Biosimulation Technology Market - Precision Modeling, Transformative Insights: B …
Newark, New Castle, USA: The "Biosimulation Technology Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Biosimulation Technology Market: https://www.growthplusreports.com/report/biosimulation-technology-market/7766
This latest report researches the industry structure, sales, revenue,…